PINCUS & CO. WARBURG
CIK 929408 · last filed 2024-03-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$19.55B
Companies
30
Total Filings
57
Lifetime Open-Market Net
-$19.77B
Filer Profile
Reported Address
450 LEXINGTON AVENUENEW YORK
NY, NY 100173147
Phone
(212) 878-0600
State of Incorporation
NY
Formerly Known As
WARBURG PINCUS & CO (1996–2011)
Related Filers
WARBURG PINCUS LLC — 476 joint filings, latest 2026-05-15
CHARLES R KAYE — 318 joint filings, latest 2020-01-14
Joseph P. Landy — 312 joint filings, latest 2019-11-29
Warburg Pincus Partners LLC — 311 joint filings, latest 2014-09-10
Warburg Pincus X, L.P. — 175 joint filings, latest 2021-04-15
Warburg Pincus X GP L.P. — 174 joint filings, latest 2021-04-15
Warburg Pincus Private Equity X, L.P. — 134 joint filings, latest 2021-04-15
Warburg Pincus Private Equity VIII, L.P. — 133 joint filings, latest 2019-03-01
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SHC | Director | 88,822,952 | $18.37 | $1.63B | -$4.85B | 2 | 2024-03-06 |
| ALHC | Director | 20,648,785 | $12.61 | $260.38M | -$225.47M | 2 | 2022-08-16 |
| SOC Telemed, Inc. (TLMDW) Delisted | Director | 0 | $0.84 | $0 | $0 | 1 | 2022-04-07 |
| Vital Energy, Inc. (LPI) Delisted | 10%+ Owner | 0 | $48.09 | $0 | -$216.58M | 2 | 2020-11-30 |
| CRWD | Director | 39,975,420 | $206.74 | $8.26B | $0 | 1 | 2020-06-05 |
| Silk Road Medical Inc (SILK) Delisted | 10%+ Owner | 7,406,301 | $27.49 | $203.60M | -$74.66M | 1 | 2019-08-15 |
| Triton International Ltd (TRTN) Delisted | Director | 0 | $79.55 | $0 | -$1.11B | 1 | 2019-03-21 |
| AR | Director | 0 | $38.43 | $0 | -$329.7K | 1 | 2018-11-09 |
| BPI | Director | 9,638,285 | $24.37 | $234.87M | $0 | 1 | 2017-03-14 |
| Endurance International Group Holdings, Inc. (EIGI) Delisted | Director | 38,732,344 | — | — | -$1.60B | 3 | 2016-09-21 |
| BLDR | 10%+ Owner | 13,263,266 | $60.37 | $800.70M | -$817.54M | 5 | 2015-11-25 |
| China Biologic Products, Inc. (CBPO) Delisted | Director | 8,344,200 | $119.99 | $1.00B | -$2.45B | 3 | 2015-06-17 |
| Santander Consumer USA Holdings Inc. (SC) Delisted | Director | 5,023,976 | $41.60 | $209.00M | -$4.50B | 1 | 2014-01-30 |
| ARMK | Director | 40,711,877 | $58.55 | $2.38B | -$342.41M | 1 | 2013-12-18 |
| WBS | Director | 4,179,920 | $77.57 | $324.24M | -$4.45B | 3 | 2013-05-14 |
| TRGP | 10%+ Owner | 2,643,385 | $290.25 | $767.24M | $0 | 3 | 2013-02-20 |
| FIS | Director | 41,303,303 | $38.14 | $1.58B | $0 | 3 | 2012-12-03 |
| PRI | Director | 10,676,303 | $292.44 | $3.12B | -$1.35B | 1 | 2012-04-27 |
| Ceres, Inc. (CERE) Delisted | Director | — | $44.96 | — | $0 | 1 | 2012-02-23 |
| NATIONAL PENN BANCSHARES INC (NPBC) Delisted | Director | 25,763,572 | — | — | $14.32M | 2 | 2011-09-07 |
| Polypore International, Inc. (PPO) Delisted | 10%+ Owner | 15,816,512 | — | — | -$287.32M | 3 | 2010-04-30 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | 10%+ Owner | 22,907,488 | — | — | $280.00M | 1 | 2009-08-10 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | 18,115 | $18.62 | $337.3K | -$218.3K | 1 | 2009-07-17 |
| Altus Pharmaceuticals Inc. (ALTU) Delisted | 10%+ Owner | 3,291,962 | $10.12 | $33.31M | -$576.4K | 1 | 2009-04-09 |
| BILL BARRETT CORP (BBG) Delisted | 10%+ Owner | 13,062,858 | — | — | $4.60M | 4 | 2008-12-05 |
| NEUROGEN CORP (NRGN) Delisted | Director | 13,571,411 | — | — | $0 | 1 | 2008-07-28 |
| ZYMOGENETICS INC (ZGEN) Delisted | 10%+ Owner | 9,069,771 | $12.01 | $108.93M | $9.12M | 2 | 2008-03-11 |
| NYFIX INC (NYFX) Delisted | 10%+ Owner | 2,492,227 | — | — | $8.39M | 1 | 2008-03-06 |
| MBI | 10%+ Owner | 40,820,391 | $4.64 | $189.41M | $2.40B | 1 | 2008-02-14 |
| SCIENTIFIC LEARNING CORP (SCIL) Delisted | 10%+ Owner | 1,375,000 | — | — | -$229.85M | 1 | 2007-08-15 |
Recent Filings · Page 6 of 6
57 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-03-11 | ZYMOGENETICS INC (ZGEN) Delisted | Buy (P) | +340,332 | $2.93M | EDGAR |
| 2008-03-10 | BLDR | Buy (P) | +314,272 | $2.05M | EDGAR |
| 2008-03-10 | BILL BARRETT CORP (BBG) Delisted | Other (J) | −10,012,380 | $0 | EDGAR |
| 2008-03-06 | NYFIX INC (NYFX) Delisted | Buy (P) | +2,041,900 | $8.39M | EDGAR |
| 2008-03-03 | ZYMOGENETICS INC (ZGEN) Delisted | Buy (P) | +618,906 | $6.19M | EDGAR |
| 2008-02-14 | MBI | Buy (P) | +197,530,872 | $2.40B | EDGAR |
| 2007-08-15 | SCIENTIFIC LEARNING CORP (SCIL) Delisted | Sell (S) | −45,969,828 | -$229.85M | EDGAR |
Showing 51–57 of 57
Prev
Page 6 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.